PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: PEPTIDES+ (ANTI-AGING)
DRUG NAME: EPITALON

• FDA Safety Data Sheet not available (experimental peptide).

• Araj SK. Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. Int J Mol Sci. 2025 [PubMed Link]

• Yue X. Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging. 2022 [PubMed Link]

• Ivko OM. Peptidergic regulation of expression of cellular aging marker proteins in buccal epithelium. Adv Gerontol. 2024 [PubMed Link]

• Ullah S. Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development. Life Sci. 2025 [PubMed Link]

• Gatta M. The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy. Stem Cell Rev Rep. 2025 [PubMed Link]

• Avolio F. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. Int J Mol Sci. 2022 [PubMed Link]

• Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002 [PubMed Link]

• Korkushko OV. Effect of peptide preparation epithalamin on circadian rhythm of epiphyseal melatonin-producing function in elderly people. Bull Exp Biol Med. 2004 [PubMed Link]

• Khavinson V. The role of peptides in aging control: results and prospects of research. Vestn Ross Akad Med Nauk. 2010 [PubMed Link]

• Anisimov VN. Twenty years of study on effects of pineal peptide preparation: epithalamin in experimental gerontology and oncology. Ann N Y Acad Sci. 1994 [PubMed Link]